Centiva Capital’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $291K | Buy |
45,464
+17,242
| +61% | +$111K | ﹤0.01% | 900 |
|
|
2025
Q1 | $99.9K | Sell |
28,222
-5,609
| -17% | -$19.9K | ﹤0.01% | 1210 |
|
|
2024
Q4 | $128K | Buy |
+33,831
| New | +$128K | ﹤0.01% | 1122 |
|
|
2024
Q3 | – | Sell |
-90,733
| Closed | -$172K | – | 1534 |
|
|
2024
Q2 | $172K | Buy |
+90,733
| New | +$172K | ﹤0.01% | 1275 |
|
|
2024
Q1 | – | Sell |
-19,188
| Closed | -$282K | – | 1353 |
|
|
2023
Q4 | $282K | Buy |
+19,188
| New | +$282K | 0.01% | 799 |
|